Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Skin papilloma
ADR ID BADD_A04056
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.10      Cutaneous neoplasms benign
23.10.01      Skin neoplasms benign
23.10.01.002      Skin papilloma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.26      Cutaneous neoplasms benign
16.26.01      Skin neoplasms benign
16.26.01.002      Skin papilloma
11      Infections and infestations
11.05      Viral infectious disorders
11.05.07      Papilloma viral infections
11.05.07.001      Skin papilloma
Description A disorder characterized by the presence of one or more warts. [CTCAE] Benign epidermal proliferations or tumors; some are viral in origin. [MeSH]
MedDRA Code 10040907
MeSH ID D014860
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Common wart | Common warts | Flat warts | Intermediate warts | Non-genital warts NOS | Other specified viral warts | Papilloma of axilla | Papilloma of face | Papilloma of scalp | Papilloma of skin | Papilloma skin | Planar warts | Plantar warts | Skin papilloma | Verruca | Verruca viral | Verruca vulgaris | Viral warts | Viral warts, unspecified | Wart | Wart (viral) | Warts | Warts (viral) | Filiform wart | Verrucous cyst | Verrucas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01773Pimecrolimus--
BADD_D01790Podofilox--
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01831Prednisolone0.000052%
BADD_D01852Progesterone--
BADD_D01906Raltegravir potassium--
BADD_D01922Regorafenib--
BADD_D01933Ribavirin0.007912%
BADD_D01951Risperidone--
BADD_D01956Rivastigmine tartrate--
BADD_D01966Ropinirole--
BADD_D01978Ruxolitinib0.000700%
BADD_D01980Salicylic acid--
BADD_D01989Saquinavir mesylate--
BADD_D02031Sitaxentan--
BADD_D02058Sorafenib0.000873%
BADD_D02105Tacrolimus0.001396%
BADD_D02223Tiopronin--
BADD_D02236Tofacitinib0.004340%
BADD_D02257Trametinib--
BADD_D02258Trametinib dimethyl sulfoxide--
BADD_D02321Ursodiol--
BADD_D02329Valproic acid0.000150%
BADD_D02344Vemurafenib0.006391%
BADD_D02407Upadacitinib0.001350%
BADD_D02464Fingolimod0.007981%
BADD_D02492Deflazacort0.000117%
BADD_D02591Ripretinib0.000627%
The 2th Page    First    Pre   2    Total 2 Pages